Literature DB >> 30242103

Authors' Reply.

Julie H Ishida1,2, Charles E McCulloch3, Michael A Steinman4,2, Barbara A Grimes3, Kirsten L Johansen4,2,3.   

Abstract

Keywords:  United States Renal Data System; gabapentin; hemodialysis; pregabalin

Mesh：

Substances：

Year:  2018        PMID： 30242103      PMCID： PMC6218857          DOI： 10.1681/ASN.2018080811

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  4 in total

Review 1.  Opioid and benzodiazepine use in end-stage renal disease: a systematic review.

Authors:  Ahraaz Wyne; Raman Rai; Meaghan Cuerden; William F Clark; Rita S Suri
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 8.237

2.  Gabepentinoids and Benzodiazepines in Medicare Part D.

Authors:  Eric D Weinhandl
Journal:  J Am Soc Nephrol       Date:  2018-09-21       Impact factor: 10.121

3.  Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients.

Authors:  Julie H Ishida; Charles E McCulloch; Michael A Steinman; Barbara A Grimes; Kirsten L Johansen
Journal:  J Am Soc Nephrol       Date:  2018-06-05       Impact factor: 10.121

4.  Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders.

Authors:  Michael K Ong; Lily Zhang; Haiyong Xu; Francisca Azocar; Susan L Ettner
Journal:  Psychiatr Serv       Date:  2012-07       Impact factor: 3.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.